Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Cancer nanomedicine: is targeting our target?
HTML
Details
Locations
Year:
2016
Type:
article
Source:
Nature Reviews Materials
DOI:
10.1038/natrevmats.2016.69
Authors:
Twan Lammers,
Fabian Kiessling,
Marianne Ashford,
Wim Hennink,
Daan Crommelin,
Gert Storm
show all 6
Institutions:
Utrecht University,
Universitätsklinikum Aachen,
University of Twente,
AstraZeneca (United Kingdom)
Language:
English
Topic:
Nanoparticle-Based Drug Delivery
Subfield:
Biomaterials
Field:
Materials Science
Domain:
Physical Sciences
Keywords:
cancer nanomedicine,
drug delivery,
targeted drug delivery,
patient benefit,
cancer therapy
SDG:
Good health and well-being
Open Access status:
green
Funders:
Deutsche Forschungsgemeinschaft,
H2020 European Research Council
Awards:
G2844955175,
Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies,
G3621515815,
G6610374903
OpenAlex ID:
W2510123569
FWCI:
9.735
Cites:
5
Cited by:
242
Related to:
10